Odour identification test and its relation to cardiac 123I- metaiodobenzylguanidine in patients with drug induced parkinsonism

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 78, Issue 11, 2007, Pages 1250-1252

  Phil, Hyu Lee ^a   Seung, Hyeon Yeo ^a   Seok, Woo Yong ^a   Yun, Joong Kim ^b  

^a Ajou University School of Medicine   (South Korea)

^b Hallym University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

METAIODOBENZYLGUANIDINE I 123; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; (3 IODOBENZYL)GUANIDINE; DIAGNOSTIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS CULTURAL SMELL IDENTIFICATION SCORE; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DRUG INDUCED PARKINSONISM; EXTRAPYRAMIDAL SYNDROME; FEMALE; FUNCTION TEST; HUMAN; MALE; PARKINSONISM; PRIORITY JOURNAL; SMELLING; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; FOLLOW UP; HEART; MEDIASTINUM; MIDDLE AGED; ODOR; PARKINSON DISEASE; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SMELLING DISORDER;

3-IODOBENZYLGUANIDINE; AGED; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; HEART; HUMANS; MALE; MEDIASTINUM; MIDDLE AGED; OLFACTION DISORDERS; PARKINSON DISEASE, SECONDARY; SMELL; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 35748956734     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2007.121285     Document Type: Article

References (19)

1. Benito-Leon J, Bermejo-Pareja F, Morales-Gonzalez JM, et al. Incidence of Parkinson disease and parkinsonism in three elderly populations of central Spain. Neurology 2004;62:734-41.
2. de Lau LM, Giesbergen PC, de Rijk MC, et al. Incidence of parkinsonism and Parkinson disease in a general population: the Rotterdam Study. Neurology 2004;63:1240-4.
3. Hardie RJ, Lees AJ. Neuroleptic-induced Parkinson's syndrome: clinical features and results of treatment with levodopa. J Neurol Neurosurg Psychiatry 1988;51:850-4.
4. Stephen PJ, Williamson J. Drug-induced parkinsonism in the elderly. Lancet 1984;2:1082-3.
5. 18F-dopa PET study. Neurology 1993;43:552-6.
6. Katzenschlager R, Lees AJ. Olfaction and Parkinson's syndromes: its role in differential diagnosis. Curr Opin Neurol 2004;17:417- 23.
7. Ponsen MM, Stoffers D, Booij J, et al. Idiopathic hyposmia as a preclinical sign of Parkinson's disease. Ann Neurol 2004;56:173-81.
8. 123I-MIBG scintigraphy in patients with drug induced parkinsonism. J Neurol Neurosurg Psychiatry 2006;77:372-4.
9. Hughes AJ, Daniel SE, Kilford L, et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-4.
10. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967;17:427-42.
11. Doty RL, Mishra A. Olfaction and its alteration by nasal obstruction, rhinitis, and rhinosinusitis. Laryngoscope 2001;111:409-23.
12. Djordjevic J, Jones-Gorman M, De Sousa K, et al. Olfaction in patients with mild cognitive impairment and Alzheimer's disease. Neurobiol Aging. 2007 (online first: 4 Jan 2007, doi:10.1016/j.neurobiolaging.2006. 11.014).
13. Frye RE, Schwartz BS, Doty RL. Dose-related effects of cigarette smoking on olfactory function. JAMA 1990;263:1233-6.
14. Double KL, Rowe DB, Hayes M, et al. Identifying the pattern of olfactory deficits in Parkinson disease using the brief smell identification test. Arch Neurol 2003;60:545-9.
15. Tolosa E, Coelho M, Gallardo M. DAT imaging in drug-induced and psychogenic parkinsonism. Mov Disord, 2003;18(Suppl 7):S28-33.
16. Braak H, Del Tredici K, Rub U, et al. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003;24:197-211.
17. Iwanaga K, Wakabayashi K, Yoshimoto M, et al. Lewy body-type degeneration in cardiac plexus in Parkinson's and incidental Lewy body diseases. Neurology 1999;52:1269-71.
18. Ross GW, Abbott RD, Petrovitch H, et al. Association of olfactory dysfunction with incidental Lewy bodies. Mov Disord 2006;21:2062-7.
19. 123I-MIBG and odor identification in patients with Parkinson's disease and multiple system atrophy. Mov Disord 2006;21:1975-7.